NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

中國的經腸營養市場分析 (2021年∼2025年)

Investigation Report on China's Enteral Nutrition Market 2021-2025

出版商 China Research and Intelligence 商品編碼 1010193
出版日期 內容資訊 英文 50 Pages
商品交期: 最快1-2個工作天內
價格
中國的經腸營養市場分析 (2021年∼2025年) Investigation Report on China's Enteral Nutrition Market 2021-2025
出版日期: 2021年06月08日內容資訊: 英文 50 Pages
簡介

經腸營養,主要是給予食慾不振及機械性腸胃功能障礙,重病,營養失調等相關疾病的患者的術前攝食。由Fresenius Kabi開發,1995年中國也上市。2020年時有8家公司進入中國市場。

中國國內的經腸營養的銷售量,從2016年到2019年逐年踏實增加。但2020年,因為COVID-19感染擴大,對醫院的診斷、治療服務產生很大的影響,經腸營養的市場規模也略為減少,2020年達11億5500萬人民幣。還有從2016年到2020年的年複合成長率為約6.5%。

今後,由於COVID-19抑制和醫療服務的改善等要素,中國國內的經腸營養的市場規模預計從2021年到2025年恢復。

本報告提供中國的經腸營養的市場相關分析,產品的概要和授權情形,整體市場規模趨勢預測,各地區的詳細趨勢,市場價格趨勢預測,主要企業的簡介與市場佔有率,主要的推動及阻礙市場要素,新型冠狀病毒感染疾病 (COVID-19)的影響等彙整資訊,為您概述為以下內容。

目錄

第1章 經腸營養的相關概念

  • 經腸營養的適應症
  • 中國國內的經腸營養的開發趨勢
  • 中國政府的經腸營養的核準情況
  • COVID-19對中國的經腸營養銷售的影響

第2章 中國國內的經腸營養銷售趨勢 (2016年∼2020年)

  • 經腸營養的銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 經腸營養的銷售量
    • 整體銷售量
    • 各地區的銷售量
  • 中國國內的經腸營養銷售趨勢:各劑型 (2016年∼2020年)
    • 懸浮液
    • 口服粉末
    • 口服乳膠

第3章 中國的經腸營養主要製造商分析 (2016年∼2020年)

  • 主要經腸營養製造商市場佔有率分析
    • 市場佔有率:銷售額為基礎
    • 市場佔有率:銷售量為基礎
  • Niudi Xiya Pharmaceutical (Wuxi) Co.,ltd.
    • 企業簡介
    • 中國的經腸營養銷售趨勢
  • Fresenius Kabi Deutschland GmbH
  • Fresenius Kabi Huarui Pharmaceutical Co., Ltd.
  • Abbott Laboratories BV
  • Milupa GmnH & Co KG

第4章 中國的經腸營養的價格趨勢:各主要製造商 (2020年∼2021年)

  • Niudi Xiya Pharmaceutical (Wuxi) Co.,ltd. (PEPTISON)
  • Fresenius Kabi Deutschland GmbH (FRESUBIN)
  • Fresenius Kabi Huarui Pharmaceutical Co., Ltd. (FRESUBIN DIABETES, FRESUBIN 750MCT, Ruineng)
  • Abbott Laboratories BV (JEVITY)
  • Milupa GmnH & Co KG(NUTRISON)

第5章 中國的經腸營養市場未來展望 (2021年∼2025年)

  • 左右中國的經腸營養市場趨勢的要素
    • COVID-19對中國的經腸營養市場的影響
    • 市場促進因素和機會
    • 市場威脅與課題
  • 市場規模的預測
  • 市場趨勢的預測
目錄
Product Code: 2106521

Enteral nutrition is mainly used for preoperative feeding of patients with anorexia and related diseases, including mechanical gastrointestinal dysfunction, critical illness and malnutrition. It was developed by Fresenius Kabi and was China in 1995. Chinese market. By 2020, in addition to Niudi Xiya Pharmaceutical (Wuxi) Co.,ltd., there are Fresenius Kabi Deutschland GmbH, Fresenius Kabi Huarui Pharmaceutical Co., Ltd., Abbott Laboratories BV, and Milupa GmnH & Co KG and other 8 manufacturers in China's Enteral Nutrition market.

According to CRI analysis, the sales value of Enteral Nutrition in China has grown steadily year by year from 2016 to 2019. In 2020, due to the impact of the COVID-19 epidemic on the hospital's overall diagnosis and treatment services, the sales value of Enteral Nutrition in China fell slightly, reached CNY1.155 billion in 2020. The CAGR of the sales value of Enteral Nutrition is about 6.5% from 2016 to 2020 in China.

CRI expects that with the effective relief of the COVID-19 epidemic, the sales of Enteral Nutrition in the Chinese market will have a restorative growth from 2021 to 2025. In addition, Enteral Nutrition is widely used clinically. With the improvement and popularization of medical services in China, the demand for Enteral Nutrition will continue to increase, so the sales of Enteral Nutrition in China will maintain a growing trend.

Topics Covered:

  • The impact of COVID-19 on China's Enteral Nutrition market
  • Sales value of China's Enteral Nutrition 2016-2020
  • Competitive landscape of China's Enteral Nutrition market
  • Prices of Enteral Nutrition in China
  • Prices of Enteral Nutrition in China by regions and manufacturers
  • Analysis on factors affecting the development of China's Enteral Nutrition market
  • Prospect of China's Enteral Nutrition market from 2021 to 2025

Table of Contents

1 Relevant Concepts of Enteral Nutrition

  • 1.1 Indications for Enteral Nutrition
  • 1.2 Development of Enteral Nutrition in China
  • 1.3 Governmental Approval of Enteral Nutrition in China
  • 1.4 The Impact of COVID-19 on Enteral Nutrition sales in China

2 Sales of Enteral Nutrition in China, 2016-2020

  • 2.1 Sales Value of Enteral Nutrition
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Region
  • 2.2 Sales Volume of Enteral Nutrition
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Region
  • 2.3 Sales of Enteral Nutrition by Dosage Form in China, 2016-2020
    • 2.3.1 Suspension
    • 2.3.2 Oral Powder
    • 2.3.3 Oral Emulsion

3 Analysis of Major Enteral Nutrition Manufacturers in China, 2016-2020

  • 3.1 Analysis of Market Share of Major Enteral Nutrition Manufacturers
    • 3.1.1 Investigation on Market Share by Sales Value
    • 3.1.2 Investigation on Market Share by Sales volume
  • 3.2 Niudi Xiya Pharmaceutical (Wuxi) Co.,ltd.
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of PEPTISON (Niudi Xiya Pharmaceutical (Wuxi) Co.,ltd.'s Enteral Nutrition) in China
  • 3.3 Fresenius Kabi Deutschland GmbH
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of FRESUBIN (Fresenius Kabi Deutschland GmbH's Enteral Nutrition) in China
  • 3.4 Fresenius Kabi Huarui Pharmaceutical Co., Ltd.
    • 3.4.1 Enterprise Profile
    • 3.4.2 Sales of FRESUBIN DIABETES, FRESUBIN 750MCT, Ruineng (Fresenius Kabi Huarui Pharmaceutical Co., Ltd.'s Enteral Nutrition) in China
  • 3.5 Abbott Laboratories BV
    • 3.5.1 Enterprise Profile
    • 3.5.2 Sales of JEVITY (Abbott Laboratories BV's Enteral Nutrition) in China
  • 3.6 Milupa GmnH & Co KG
    • 3.6.1 Enterprise Profile
    • 3.6.2 Sales of NUTRISON (Milupa GmnH & Co KG's Enteral Nutrition) in China

4 Prices of Enteral Nutrition for Different Manufacturers in China, 2020-2021

  • 4.1 Niudi Xiya Pharmaceutical (Wuxi) Co.,ltd. (PEPTISON)
  • 4.2 Fresenius Kabi Deutschland GmbH (FRESUBIN)
  • 4.3 Fresenius Kabi Huarui Pharmaceutical Co., Ltd. (FRESUBIN DIABETES, FRESUBIN 750MCT, Ruineng)
  • 4.4 Abbott Laboratories BV (JEVITY)
  • 4.5 Milupa GmnH & Co KG(NUTRISON)

5 Prospect of Chinese Enteral Nutrition Market, 2021-2025

  • 5.1 Influential Factors of Chinese Enteral Nutrition Market Development
    • 5.1.1 The Impact of COVID-19 on Chinese Enteral Nutrition Market
    • 5.1.2 Market Drivers and Opportunities
    • 5.1.3 Market Threats and Challenges
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

List of Charts

  • Chart Patent Information About Enteral Nutrition Suspension Registration in China
  • Chart Patent Information About Enteral Nutrition Oral Powder Registration in China
  • Chart Patent Information About Enteral Nutrition Oral Emulsion Registration in China
  • Chart Sales Value of Enteral Nutrition Suspension over the World
  • Chart Sales Value of Enteral Nutrition Oral Powder over the World
  • Chart Sales Value of Enteral Nutrition Oral Emulsion over the World
  • Chart Sales Value of Enteral Nutrition Suspension in China, 2016-2020
  • Chart Sales Value of Enteral Nutrition Oral Powder in China, 2016-2020
  • Chart Sales Value of Enteral Nutrition Oral Emulsion in China, 2016-2020
  • Chart Sales Value of Enteral Nutrition Suspension in China by Region, 2016-2020
  • Chart Sales Value of Enteral Nutrition Oral Powder in China by Region, 2016-2020
  • Chart Sales Value of Enteral Nutrition Oral Emulsion in China by Region, 2016-2020
  • Chart Sales Volume of Enteral Nutrition Suspension in China, 2016-2020
  • Chart Sales Volume of Enteral Nutrition Oral Powder in China, 2016-2020
  • Chart Sales Volume of Enteral Nutrition Oral Emulsion in China, 2016-2020
  • Chart Sales Volume of Enteral Nutrition Suspension in China by Region, 2016-2020
  • Chart Sales Volume of Enteral Nutrition Oral Powder in China by Region, 2016-2020
  • Chart Sales Volume of Enteral Nutrition Oral Emulsion in China by Region, 2016-2020
  • Chart Market Share by Sales Value of Top Enteral Nutrition Suspension Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Enteral Nutrition Oral Powder Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Enteral Nutrition Oral Emulsion Manufacturers in China, 2016-2020
  • Chart Sales Value and Volume of PEPTISON in China, 2016-2020
  • Chart Sales Value and Volume of FRESUBIN in China, 2016-2020
  • Chart Sales Value and Volume of FRESUBIN DIABETES, FRESUBIN 750MCT, Ruineng in China, 2016-2020
  • Chart Sales Value and Volume of JEVITY in China, 2016-2020
  • Chart Sales Value and Volume of NUTRISON in China, 2016-2020
  • Chart Referential Prices of PEPTISON in China by Region, 2020-2021
  • Chart Referential Prices of FRESUBIN in China by Region, 2020-2021
  • Chart Referential Prices of FRESUBIN DIABETES, FRESUBIN 750MCT, Ruineng in China by Region, 2020-2021
  • Chart Referential Prices of JEVITY in China by Region, 2020-2021
  • Chart Referential Prices of NUTRISON in China by Region, 2020-2021
  • Chart Forecast on Sales Value of Enteral Nutrition Suspension in China, 2021-2025
  • Chart Forecast on Sales Value of Enteral Nutrition Oral Powder in China, 2021-2025
  • Chart Forecast on Sales Value of Enteral Nutrition Oral Emulsion in China, 2021-2025
  • Chart Forecast on Sales Volume of Enteral Nutrition Suspension in China, 2021-2025
  • Chart Forecast on Sales Volume of Enteral Nutrition Oral Powder in China, 2021-2025
  • Chart Forecast on Sales Volume of Enteral Nutrition Oral Emulsion in China, 2021-2025